Crossmark

Indium-111-labeled CD166-targeted peptide as a potential nuclear imaging agent for detecting colorectal cancer stem-like cells in a xenograft mouse model

Crossref DOI link: https://doi.org/10.1186/s13550-020-0597-3

Published Online: 2020-02-24

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guan, Siao-Syun

Wu, Cheng-Tien

Liao, Tse-Zung

Luo, Tsai-Yueh

Lin, Kun-Liang

Liu, Shing-Hwa http://orcid.org/0000-0002-9976-1197
Funding

Funding for this research was provided by:

Atomic Energy Council, Executive Yuan, Taiwan (107-2001-02-17-03)

Ministry of Science and Technology, Taiwan (MOST 106-3111-Y-042A-090)
License Information

Text and Data Mining valid from 2020-02-24

Version of Record valid from 2020-02-24
More Information

Article History

Received: 25 November 2019

Accepted: 17 January 2020

First Online: 24 February 2020

Ethics approval and consent to participate

: All animal studies were approved by the ethical review committee of the Institute of Nuclear Energy Research, Atomic Energy Council, Taoyuan, Taiwan (approval no.107175) and were carried out in accordance with regulations of Taiwan and NIH guidelines on the care and welfare of laboratory animals.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below